IRIS
QUARTUCCIO, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.622
AS - Asia 8.565
EU - Europa 4.820
SA - Sud America 1.601
Continente sconosciuto - Info sul continente non disponibili 1.005
AF - Africa 204
OC - Oceania 10
AN - Antartide 1
Totale 32.828
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.275
SG - Singapore 3.964
CN - Cina 1.704
BR - Brasile 1.254
UA - Ucraina 1.062
IT - Italia 869
HK - Hong Kong 867
VN - Vietnam 777
DE - Germania 678
FI - Finlandia 416
RU - Federazione Russa 362
FR - Francia 357
GB - Regno Unito 257
BD - Bangladesh 244
IE - Irlanda 242
SE - Svezia 223
IN - India 205
TR - Turchia 193
CA - Canada 180
AR - Argentina 123
KR - Corea 112
EC - Ecuador 68
JP - Giappone 68
ID - Indonesia 67
AT - Austria 66
IQ - Iraq 66
MX - Messico 64
ZA - Sudafrica 64
NL - Olanda 57
CO - Colombia 50
PL - Polonia 45
ES - Italia 36
PK - Pakistan 36
CZ - Repubblica Ceca 29
EG - Egitto 29
UZ - Uzbekistan 29
IR - Iran 28
SA - Arabia Saudita 26
VE - Venezuela 26
BE - Belgio 25
JM - Giamaica 25
MA - Marocco 25
CL - Cile 24
PH - Filippine 23
PY - Paraguay 23
TG - Togo 20
TN - Tunisia 18
AE - Emirati Arabi Uniti 17
CR - Costa Rica 16
LT - Lituania 16
MY - Malesia 15
TT - Trinidad e Tobago 14
UY - Uruguay 13
AZ - Azerbaigian 12
DO - Repubblica Dominicana 11
JO - Giordania 11
KE - Kenya 11
KZ - Kazakistan 11
OM - Oman 11
BO - Bolivia 10
GR - Grecia 10
NP - Nepal 10
PE - Perù 10
PT - Portogallo 10
AL - Albania 9
DZ - Algeria 9
IL - Israele 9
TH - Thailandia 9
HN - Honduras 7
LB - Libano 7
RO - Romania 7
TW - Taiwan 7
EE - Estonia 6
EU - Europa 6
GT - Guatemala 6
KG - Kirghizistan 6
LK - Sri Lanka 6
BY - Bielorussia 5
HR - Croazia 5
NZ - Nuova Zelanda 5
AU - Australia 4
BB - Barbados 4
BS - Bahamas 4
CH - Svizzera 4
ET - Etiopia 4
NI - Nicaragua 4
NO - Norvegia 4
PA - Panama 4
RS - Serbia 4
BN - Brunei Darussalam 3
GA - Gabon 3
KW - Kuwait 3
PS - Palestinian Territory 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
CY - Cipro 2
DK - Danimarca 2
Totale 31.780
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.633
Singapore 1.595
Ashburn 1.202
Ann Arbor 1.122
Fairfield 1.061
Houston 984
Beijing 858
Hong Kong 840
Chandler 767
Council Bluffs 730
San Jose 706
Jacksonville 683
Wilmington 521
Seattle 445
Boardman 418
Dearborn 415
Cambridge 335
Lauterbourg 285
Los Angeles 260
Ho Chi Minh City 242
Dublin 239
Princeton 229
Udine 181
Dallas 176
Santa Clara 140
Izmir 139
Hanoi 138
Buffalo 130
Hefei 129
São Paulo 126
Helsinki 107
New York 107
Seoul 105
Redondo Beach 97
Des Moines 86
San Diego 84
Milan 83
Dong Ket 80
Munich 79
Nuremberg 73
The Dalles 70
Ogden 60
Orem 57
Phoenix 56
Frankfurt am Main 55
Norwalk 50
Ottawa 44
Tokyo 44
London 43
Redmond 42
Warsaw 41
Atlanta 40
Montreal 40
Brooklyn 39
Rome 39
Nanjing 38
Toronto 38
Johannesburg 37
Rio de Janeiro 37
Chicago 36
Mumbai 35
Trieste 35
Denver 31
Pittsburgh 31
Amsterdam 30
Chennai 30
Belo Horizonte 28
Da Nang 28
Stockholm 28
Tashkent 28
Haiphong 27
Belluno 26
San Mateo 26
Lappeenranta 25
San Francisco 25
Düsseldorf 24
Guangzhou 24
Quito 24
Curitiba 23
Guayaquil 23
Vienna 23
Brasília 22
Brno 21
Turku 21
Baghdad 20
Brussels 20
Hải Dương 20
Lomé 20
Boston 19
Mexico City 19
Salvador 19
Shanghai 19
Manchester 18
Kingston 17
Porto Alegre 17
Washington 17
Biên Hòa 16
Goiânia 16
Kunming 16
Poplar 16
Totale 19.463
Salva come PNG Salva come JPEG
Nome #
Efficacy and safety of belimumab in primary Sjogren's syndrome: results of the BELISS open-label phase II study. 206
An overview on advantages and limitations of serological assays for saRs-coV-2 infectious disease 203
Differentiation between early rheumatoid and early psoriatic arthritis by the ultrasonographic study of the synovio-entheseal complex of the small joints of the hands 197
Development of the ClinESSDAI: A clinical score without biological domain. A tool for biological studies 192
A randomized controlled trial of rituximab for treatment of severe cryoglobulinemic vasculitis. 191
Gitelman syndrome disclosed by calcium pyrophosphate deposition disease: Early diagnosis by ultrasonographic study 191
Biomarkers of lymphoma in Sjögren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study. 190
Pain management in cryoglobulinaemic syndrome 188
A randomized, controlled, multicenter phase iii study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) Ann Rheum Dis 2010;69(Suppl3):93 187
AB0695 Anti-prothrombin/phosphatidyl-serine complex autoantibodies in antiphospholipid syndrome: Preliminary data using a new ELISA method 187
Validation of the classification criteria for cryoglobulinaemic vasculitis. 185
Acetaminophen-induced liver injury in a woman with febrile flare of systemic lupus erythematosus 184
Pachydermodactyly: The role of ultrasonography and dermoscopy for diagnosis 182
The CC homozygosis of the -174G>C IL-6 polymorphism predicts a lower efficacy of rituximab therapy in rheumatoid arthritis 177
Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study 174
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization. 174
Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients 172
HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2 171
A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sjögren's Syndrome related lymphoproliferation 170
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 167
Accuracy of Computer-Guided Flapless Implant Surgery in Fully Edentulous Arches and in Edentulous Arches With Fresh Extraction Sockets 167
Efficacy of intravenous cyclosporine in a case of cytophagic histiocytic panniculitis complicated by haemophagocytic syndrome after visceral leishmania infection 167
BLyS upregulation in Sjogren's syndrome associated with lymphoproliferative disorders, higher ESSDAI score and B-cell clonal expansion in the salivary glands 166
Optimizing the dose of mycophenolate mofetil for the maintenance treatment of lupus nephritis by therapeutic drug monitoring. 166
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 166
Use of teriparatide in osteoporosis due to active rheumatic diseases 165
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 165
Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjögren's syndrome: results of a large multicentre study. 164
Treatment with belimumab restores B cell subsets and their expression of B cell activating factor receptor in patients with primary Sjogren's syndrome 163
Increased genomic instability following treatment with direct acting anti-hepatitis C virus drugs 163
Prevalence of mixed cryoglobulinaemia syndrome and circulating cryoglobulins in a population-based survey: the Origgio study. 162
A randomized, controlled, multicenter phase III study of the efficacy and safety of rituximab (rtx) monotherapy versus the best available treatment (bat) in patients with mixed cryoglobulinemia syndrome (MC) 162
Cryoglobulinaemia related to Sjogren's syndrome or HCV infection: differences based on the pattern of bone marrow involvement, lymphoma evolution and laboratory tests after parotidectomy. 158
Strontium ranelate and femural fracture healing during rheumatoid arthritis and osteoporosis 157
Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients 157
Patient-reported impact of spondyloarthritis on work disability and working life: The ATLANTIS survey 156
Role e of oral cyclophosphamide in the treatment of giant cell arteritis 155
Ciclosporina e tacrolimus nella miosite da corpi inclusi: efficacia clinica, sicurezza e risparmio nell'uso dei corticosteroidi 155
Dermoscopy of nail fold and elbow in the differential diagnosis of early psoriatic arthritis sine psoriasis and early rheumatoid arthritis 155
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care 155
Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides. 154
Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis 154
Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection 154
Cost-effectiveness analysis of two Rituximab retreatment regimens for longstanding rheumatoid arthritis. 153
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 153
Treatment of rheumatoid arthritis with rituximab: an update and possible indications. 152
Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution 152
Mycophenolic Acid AUC estimation in patients with lupus nephritis using an algorithm validated in an heart transplanted population 152
Clinical follow-up predictors of disease pattern change in anti-Jo1 positive anti-synthetase syndrome: Results from a multicenter, international and retrospective study 150
Apheresis treatment of cryoglobulinemic vasculitis: A multicentre cohort study of 159 patients 150
L. Quartuccio, M. Fabris, M. Maset, E. Pontarini, A. Zabotti, S. De Vita Bone marrow b-cell expansion in mixed cryoglobulinemia: association with nephritis and response to rituximab 149
HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC) 148
Italian consensus recommendations for the management of hepatitis C infection in patients with rheumatoid arthritis 148
A TGF-β associated genetic score to define prognosis and platinum sensitivity in advanced epithelial ovarian cancer 148
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et al 145
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 145
Myositis in primary sjögren's syndrome: data from a multicenter cohort 144
B lymphocyte stimulator (BLyS) and monocytes: possible role in autoimmune diseases with a particular reference to rheumatoid arthritis 144
Long-term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus-Associated Cryoglobulinemia Vasculitis 144
Classification of cryoglobulinemic vasculitis 143
A randomized, controlled, multicenter phase III study of the efficacy and safety of Rituximab (RTX) monotherapy versus thebest available treatment in patients with mixedcryoglobulinemia syndrome, on behalf of the rituximab studygroup in cryoglobulinemic sindrome. 143
Comment on: Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis: reply 142
A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sjögren's syndrome. 141
Pregnancy and fetal outcome in patients with an established diagnosis of primary sjögren's syndrome 140
Sequential therapy with belimumab followed by rituximab in Sjögren's syndrome associated with B-cell lymphoproliferation and overexpression of BAFF: evidence for long-term efficacy. 139
Efficacy of belimumab and targeting of rheumatoid factor-positive B-cell expansion in Sjögren's syndrome: follow-up after the end of the phase II open-label BELISS study 139
Gastrointestinal Involvement in Systemic Vasculitis 139
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population-based multicentre cohort study. 138
Ultrasonographic detection of subclinical enthesitis and synovitis: a possible stratification of psoriatic patients without clinical musculoskeletal involvement 138
High T-cell response rate after COVID-19 vaccination in belimumab and rituximab recipients 137
Rituximab for rheumatoid arthritis refractory to both conventional therapy and anti-tumor necrosis factor therapy: results of a multi-centre observational italian studyann 135
Fetal Outcome in Patients with an Established Diagnosis of Primary Sjögren’s Syndrome 134
Rituximab as possible first-line therapy for glomerulonephritis in HCV-related mixed cryoglobulinaemia 134
Variations in lumbar and femural bmd after rituximab therapy in active rheumatoid arthritis 134
Efficacy and tolerability of repeated cycles of a once-weekly regimen of bortezomib in lupus. 134
Late relapses of hepatitis C virus-cured mixed cryoglobulinaemia associated with infection or cancer 134
Development of type II mixed cryoglobulinaemic syndrome after effective and persistent hepatitis C virus eradication. 133
A clinical-genetic score to identify surgically resected colorectal cancer patients benefiting from an adjuvant fluoropyrimidine-based therapy 133
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease 133
Post-covid-19 arthritis and sacroiliitis: Natural history with longitudinal magnetic resonance imaging study in two cases and review of the literature 132
Efficacy of cyclosporin-A in the long-term management of thrombocytopenia associated with systemic lupus erythematosus 131
The-308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis 131
Articular and peripheral nervous system involvement are linked to the long-term outcome in primary Sjögren's syndrome: The relevance of single organ manifestations rather than a composite score as predictors 131
Rheumatoid factor positivity, a lower disability and a lower number of anti-tnf agents failed are associated with response to rituximab in rheumatoid arthritis 130
Clinical characterization and treatment outcome in a monocentric cohort of 45 patients with adult onset still's disease 129
Type I interferon signature may influence the effect of belimumab on immunoglobulin levels, including rheumatoid factor in Sjögren's syndrome 129
The role of the il-6 promoter p in predicting rituximab efficacy in rheumatoid artolymorphism 128
efficacy of methotrexate in polymyalgia rheumatica 128
Delayed Positivization of Cerebral Angiography in Reversible Cerebral Vasoconstriction Syndrome (RCVS) Presenting with Recurrent Subarachnoid Haemorrhage. 128
Gastrointestinal involvement in systemic vasculitis 128
Pleuritis is a red flag for Adult-onset Still's disease which may require biologic therapies. 127
Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab. 127
Preliminary classification criteria for the cryoglobulinaemic vasculitis 126
Safety of Rituximab in different rheumatic autoimmune diseases. A single centre experience in 85 cases. 2008 125
B-Lymphocyte Stimulator (BLyS) in mixed cryoglobulinemia sindrome: pathobiological and clinical implication 125
Disappearance of bone marrow B cell clonal expansion in patients with type II hepatitis C virus-related cryoglobulinemic glomerulonephritis after clinical efficient rituximab therapy. 125
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia 125
Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients 124
prevalence of chlamydophila psittaci subclinical infection in italian patients with rheumatoid arthritis: etiopathological and therapeutic implications 122
Association be tween B cell clonal expansion and glomerulonephritis in type cryoglobulinnaemia. 2007; 66 (Suppl. II): 121 121
Totale 15.166
Salva come PNG Salva come JPEG
Categoria #
all - tutte 132.848
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 132.848
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.443 0 0 89 138 44 48 91 109 25 235 369 295
2022/20232.035 248 95 38 221 208 544 35 147 296 38 77 88
2023/2024763 109 62 29 19 144 89 30 64 99 60 21 37
2024/20255.380 121 403 231 158 236 233 337 358 709 492 771 1.331
2025/202610.730 789 1.026 943 1.044 1.543 919 1.092 391 735 872 837 539
2026/20271.528 423 805 300 0 0 0 0 0 0 0 0 0
Totale 32.828